Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Annals of Internal Medicine|May 15, 1993
Risk factors for prostate cancerK J Pienta, P S Esper
Seminars in Urologic Oncology|February 1, 1997
Supportive care in the patient with hormone refractory prostate cancerP S Esper, K J Pienta
American Journal of Clinical Oncology|October 1, 1996
A phase II evaluation of oral tamoxifen and intermittent intravenous vinblastine in hormone-refractory adenocarcinoma of the prostateK J Pienta, B G Redman, P S Esper, et al.
American Journal of Clinical Oncology|February 1, 1997
Phase II chemoprevention trial of oral fenretinide in patients at risk for adenocarcinoma of the prostateK J Pienta, P S Esper, F Zwas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostateK J Pienta, B Redman, M Hussain, et al.
Urology|September 25, 1997
A phase II trial of oral estramustine and oral etoposide in hormone refractory prostate cancerK J Pienta, B G Redman, R Bandekar, et al.
In Vivo (Athens, Greece)|May 1, 1994
The epidemiology of prostate cancer: clues for chemopreventionK J Pienta
The Journal of Nursing Education|February 1, 1995
Facing transition--nurse clinician to nurse educatorP S Esper
In Vivo (Athens, Greece)|September 1, 1995
Establishment of an immortalized Copenhagen rat prostate epithelial cell lineK Yamazaki, K J Pienta
Pageof 13